STUDIES ON THE MECHANISM OF ACTION OF N-BUTYL-DEOXYNOJIRIMYCIN AS AN INHIBITOR OF HIV REPLICATION

STUDIES ON THE MECHANISM OF ACTION OF N-BUTYL-DEOXYNOJIRIMYCIN AS AN INHIBITOR OF HIV REPLICATION

Détails bibliographiques
Auteurs principaux:	Fischer, P, Collin, M, Karlsson, G, James, W, Butters, T, Gordon, S, Dwek, R, Platt, F
Format:	Journal article
Publié:	1995

Documents similaires

Improved cellular inhibitors for glycoprotein processing alpha-glucosidases: biological characterisation of alkyl- and arylalkyl-N-substituted deoxynojirimycins
par: Alonzi, D, et autres
Publié: (2009)

Preparation, biochemical characterization and biological properties of radiolabelled N-alkylated deoxynojirimycins.
par: Mellor, H, et autres
Publié: (2002)

Crystal structures of complexes of N-butyl- and N-nonyl-deoxynojirimycin bound to acid beta-glucosidase: insights into the mechanism of chemical chaperone action in Gaucher disease.
par: Brumshtein, B, et autres
Publié: (2007)

Cellular effects of deoxynojirimycin analogues: inhibition of N-linked oligosaccharide processing and generation of free glucosylated oligosaccharides.
par: Mellor, H, et autres
Publié: (2004)

Synthesis and biological characterisation of novel N-alkyl-deoxynojirimycin alpha-glucosidase inhibitors.
par: Rawlings, A, et autres
Publié: (2009)

Cellular effects of deoxynojirimycin analogues: uptake, retention and inhibition of glycosphingolipid biosynthesis.
par: Mellor, H, et autres
Publié: (2004)

The alpha-glucosidase inhibitor N-butyldeoxynojirimycin inhibits human immunodeficiency virus entry at the level of post-CD4 binding.
par: Fischer, P, et autres
Publié: (1995)

N-alkyl deoxynojirimycins as antiviral compounds.
par: Moriarty, R, et autres
Publié: (2002)

N-Butyl-L-Deoxynojirimycin (L-NBDNJ): Synthesis of an allosteric enhancer of α-glucosidase activity for the treatment of Pompe disease
par: D'Alonzo, D, et autres
Publié: (2017)

N-butyldeoxygalactonojirimycin: a more selective inhibitor of glycosphingolipid biosynthesis than N-butyldeoxynojirimycin, in vitro and in vivo.
par: Andersson, U, et autres
Publié: (2000)

Iminosugar inhibitors for treating the lysosomal glycosphingolipidoses
par: Butters, T, et autres
Publié: (2005)

Gas-phase structure and conformation of the glycosidase and ceramide glucosyltransferase inhibitor N-benzyl deoxynojirimycin
par: Jockusch, R, et autres
Publié: (2004)

Imino sugar inhibitors for treating the lysosomal glycosphingolipidoses.
par: Butters, T, et autres
Publié: (2005)

Amphiphilic 1-deoxynojirimycin derivatives through click strategies for chemical chaperoning in N370S Gaucher cells.
par: Diot, J, et autres
Publié: (2011)

Synthesis and Evaluation of Phenyltriazole-Deoxynojirimycin Hybrids as Potent α-Glucosidase Inhibitors
par: Lin Wang, et autres
Publié: (2024-10-01)

Inhibition of membrane-associated viral replication
par: Block, T, et autres
Publié: (2016)

SYNTHESIS OF DEOXYNOJIRIMYCIN AND OF NOJIRIMYCIN DELTA-LACTAM
par: Fleet, G, et autres
Publié: (1990)

Metabolic engineering of Bacillus amyloliquefaciens for efficient production of α-glucosidase inhibitor1-deoxynojirimycin
par: Xujie Li, et autres
Publié: (2023-09-01)

Membrane disruption and cytotoxicity of hydrophobic N-alkylated imino sugars is independent of the inhibition of protein and lipid glycosylation.
par: Mellor, H, et autres
Publié: (2003)

Synthesis, in vitro inhibitory activity, kinetic study and molecular docking of novel N-alkyl–deoxynojirimycin derivatives as potential α-glucosidase inhibitors
par: Ping Lin, et autres
Publié: (2020-01-01)

α-Glucosidase inhibition of lactone intermediates of the iminosugar deoxynojirimycin
par: Wai Haan, Y, et autres
Publié: (2019)

Asymmetric total synthesis of L-allo-1-deoxynojirimycin
par: Subhash P. Chavan, et autres
Publié: (2015-10-01)

Study on the Synthesis and Biological Activities of N-Alkylated Deoxynojirimycin Derivatives with a Terminal Tertiary Amine
par: Lin Wang, et autres
Publié: (2020-09-01)

Therapeutic applications of imino sugars in lysosomal storage disorders.
par: Butters, T, et autres
Publié: (2003)

New therapeutics for the treatment of glycosphingolipid lysosomal storage diseases.
par: Butters, T, et autres
Publié: (2003)

Inhibition of glycosphingolipid biosynthesis: application to lysosomal storage disorders.
par: Butters, T, et autres
Publié: (2000)

Quantitative determination of 1-deoxynojirimycin in 146 varieties of mulberry fruit
par: Zhenjiang Wang, et autres
Publié: (2021-01-01)

A formal total synthesis of deoxynojirimycin from D-glucitol
par: Braga Raquel M., et autres
Publié: (2003-01-01)

Evaluation of the anti-hyperglycemic effect and safety of microorganism 1-deoxynojirimycin.
par: Soo Takasu, et autres
Publié: (2018-01-01)

Hybrid Multivalent Jack Bean α-Mannosidase Inhibitors: The First Example of Gold Nanoparticles Decorated with Deoxynojirimycin Inhitopes
par: Costanza Vanni, et autres
Publié: (2021-09-01)

High-performance cation-exchange chromatography and pulsed amperometric detection for the separation, detection, and quantitation of N-alkylated imino sugars in biological samples.
par: Mellor, H, et autres
Publié: (2000)

Glycolipids in cell biology and medicine - Introduction
par: Dwek, R, et autres
Publié: (2003)

Introduction
par: Dwek, R, et autres
Publié: (2003)

An oxidation and ring contraction approach to the synthesis of (+/-)-1-deoxynojirimycin and (+/-)-1-deoxyaltronojirimycin.
par: Bagal, S, et autres
Publié: (2010)

Iminosugar 1-Deoxynojirimycin (DNJ) sebagai Antiviral Infeksi Virus Dengue
par: Muhammad Luthfi Adnan
Publié: (2020-12-01)

Long-term non-hormonal male contraception in mice using N-butyldeoxynojirimycin.
par: Walden, C, et autres
Publié: (2006)

N-butyldeoxynojirimycin causes weight loss as a result of appetite suppression in lean and obese mice.
par: Priestman, D, et autres
Publié: (2008)

Effects of 1-Deoxynojirimycin on glycemic control: A systematic review and meta-analysis
par: In Ho Cho, et autres
Publié: (2025-03-01)

Identification and expression of key genes related to 1-deoxynojirimycin biosynthesis in Streptomyces lavendulae
par: Xiangdong Xin, et autres
Publié: (2023-07-01)

Glycosphingolipid lysosomal storage diseases: therapy and pathogenesis.
par: Jeyakumar, M, et autres
Publié: (2002)